Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Comparative effectiveness research and outcomes of diabetes treatment.

Safford MM.

JAMA. 2014 Jun 11;311(22):2275-6. doi: 10.1001/jama.2014.4313. No abstract available.

PMID:
24915257
2.

Insulin vs sulfonylureas for second-line diabetes treatment.

Roumie CL, Greevy RA, Griffin MR.

JAMA. 2014 Oct 22-29;312(16):1694. doi: 10.1001/jama.2014.11126. No abstract available.

PMID:
25335156
3.

Insulin vs sulfonylureas for second-line diabetes treatment.

Tasci I, Safer U.

JAMA. 2014 Oct 22-29;312(16):1693. doi: 10.1001/jama.2014.11114. No abstract available.

PMID:
25335154
4.

Insulin vs sulfonylureas for second-line diabetes treatment--reply.

Roumie CL, Greevy RA, Griffin MR.

JAMA. 2014 Oct 22-29;312(16):1693-4. doi: 10.1001/jama.2014.11120. No abstract available.

PMID:
25335155
5.

Insulin vs sulfonylureas for second-line diabetes treatment--reply.

Safford MM.

JAMA. 2014 Oct 22-29;312(16):1694-5. doi: 10.1001/jama.2014.11129. No abstract available.

PMID:
25335159
6.

The phantom of lactic acidosis due to metformin in patients with diabetes.

Misbin RI.

Diabetes Care. 2004 Jul;27(7):1791-3. Review. No abstract available.

PMID:
15220268
7.

Metformin stinks, literally.

Pelletier AL, Butler AM, Gillies RA, May JR.

Ann Intern Med. 2010 Feb 16;152(4):267-8. doi: 10.7326/0003-4819-152-4-201002160-00023. No abstract available.

PMID:
20157150
8.

Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.

Berkowitz SA, Krumme AA, Avorn J, Brennan T, Matlin OS, Spettell CM, Pezalla EJ, Brill G, Shrank WH, Choudhry NK.

JAMA Intern Med. 2014 Dec;174(12):1955-62. doi: 10.1001/jamainternmed.2014.5294.

PMID:
25347323
9.

Preliminary trial of a powerful new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).

Jackson WP, Vinik AI.

S Afr Med J. 1969 Aug 9;43(32):1002-4. No abstract available.

PMID:
4898090
10.

Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.

Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, Elasy TA, Griffin MR.

JAMA. 2014 Jun 11;311(22):2288-96. doi: 10.1001/jama.2014.4312.

11.

HB419 (glibenclamide) in the treatment of diabetes mellitus.

Schneider T, Lopis S.

S Afr Med J. 1969 Aug 9;43(32):981-3. No abstract available.

PMID:
4898344
12.

Fecal incontinence resolved using metformin withdrawal.

Gerstel C, Zarate Lagunes M, Vischer UM.

J Am Geriatr Soc. 2011 Apr;59(4):756-7. doi: 10.1111/j.1532-5415.2011.03358.x. No abstract available.

PMID:
21492103
13.

Lactic acidosis in patients with diabetes treated with metformin.

Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA.

N Engl J Med. 1998 Jan 22;338(4):265-6. No abstract available.

14.

Metformin-induced hemolytic anemia.

Blum A, Ghaben W, Slonimsky G, Simsolo C.

Isr Med Assoc J. 2011 Jul;13(7):444-5. No abstract available.

15.

Metformin-induced hemolytic anemia in a patient with glucose-6- phosphate dehydrogenase deficiency.

Meir A, Kleinman Y, Rund D, Da'as N.

Diabetes Care. 2003 Mar;26(3):956-7. No abstract available.

PMID:
12610074
16.

[Early control of diabetic sequelae. Combined insulin treatment also in type 2].

[No authors listed]

MMW Fortschr Med. 2000 Jun 22;142(25):57. German. No abstract available.

PMID:
10920674
17.

Lactic acidosis in a diabetic patient treated with metformin undergoing hepatic resection.

Kelliher LJ, Fawcett WJ.

Br J Hosp Med (Lond). 2012 Apr;73(4):232-3. No abstract available.

PMID:
22585204
18.

Jaundice from diabetes therapy.

Hieronimus A, Klein R, Häring HU, Fritsche A, Wagner R.

Diabetes Care. 2014;37(3):e57-8. doi: 10.2337/dc13-2164. No abstract available.

PMID:
24558087
19.

Metformin as an adjunctive therapy for NIDDM.

Waterman PE.

Nurse Pract. 1996 Apr;21(4):150-2. No abstract available.

PMID:
8801483
20.

Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base.

Petrie MC, Boyle JG, McKay GA.

Diabet Med. 2015 Jul;32(7):981-2. doi: 10.1111/dme.12709. No abstract available.

PMID:
25645049
Items per page

Supplemental Content

Write to the Help Desk